COH29 is an orally available, aromatically substituted thiazole and inhibitor of the human ribonucleotide reductase (RNR), with potential antineoplastic activity.

Palbociclib HCl(帕布昔利布盐酸盐) is a highly selective inhibitor.

Seliciclib is an orally available small molecule and CDK inhibitor with potential apoptotic and antineoplastic activity.

SNS-032 has firstly been described as a selective inhibitor of CDK2.

AZD5438 is a potent inhibitor of CDK1/2/9.

MK-8776 is an agent targeting cell cycle checkpoint kinase 1 with potential radiosensitization and chemosensitization activities.

Palbociclib Isethionate is the isethionate salt form of palbociclib, an orally available CDK inhibitor with potential antineoplastic activity.

Abemaciclib mesylate is a potent and selective inhibitor of CDK4 and CDK6.